- Leader in quality by design and PAT initiatives with OpX Advantage
program
- Open standards and protocols pioneer
- Developing and enforcing internal use of standards for greater
efficiency and consistency on validated projects
- Investing and participating in harmonization programs
- Support of industry standards groups (S95, S88, PDA, ISPE
and others)
- Communicating benefits and sharing tools
The OpX Advantage Program combines Emerson's 30-plus years of
Life Sciences consulting and engineering, and its PlantWeb®
digital automation technology, with Lean Manufacturing and Six
Sigma business process improvement methodologies. It helps manufacturers
achieve operational excellence through the resulting implementation
of innovative pharmaceutical development, manufacturing, and quality
assurance projects.
"The Life Sciences industry is facing a 'perfect storm'
of business conditions, including growing competition, quality
and safety concerns, and new price pressures," comments Emerson
Operational Excellence business director Bob Lenich. "The
FDA's 21st-century cGMPs and PAT initiatives are helping remove
past hesitancy by Life Sciences companies to pursue innovative
solutions, but those companies are now struggling with where to
begin and how to turn their goals into realities. That's where
Emerson's OpX Advantage Program can help."
Numerous independent studies conducted across multiple industries
have revealed that while manufacturing automation accounts for
only 5-8% of total plant costs, proper application of automation
technology to plant floor business practices has enormous impact
on production efficiency and product quality. Emerson's OpX Advantage
Program quickly, efficiently, and affordably identifies what's
required functionally, operationally, and culturally to apply
and sustain the long-term benefits innovative automation solutions
can provide.
View
the OpX Advantage Flyer
